Accuracy of the Framingham Risk Score With ECG Data
This cohort study uses NHANES data to compare the ability of the Framingham risk score with vs without ECG measures to predict 10-year ischemic heart disease and all-cause mortality.
This cohort study uses NHANES data to compare the ability of the Framingham risk score with vs without ECG measures to predict 10-year ischemic heart disease and all-cause mortality.
This cohort study examines the association of the neighborhood environment with the onset and severity of menopause at midlife.
This cross-sectional study assesses the risk of cardiovascular complications in a nationwide cohort of Singaporean adults hospitalized for respiratory syncytial virus, influenza, or COVID-19 during…
This cross-sectional study evaluates whether a large language model (LLM) can use unstructured health record notes to accurately identify adult patients who had past-year residence…
This cohort study assesses whether early-life factors are associated with body mass index (BMI) trajectories in children from the Environmental influences on Child Health Outcomes…
This cohort study evaluates and describes the implementation and initial outcomes of a housing benefit program in Oregon.
This cohort study of children and adolescents aged 9 to 12 years evaluates person-level associations between time spent using social media and depressive symptoms over…
This prespecified analysis of a randomized trial examines profiles, risk, and response to finerenone among patients with hearth failure with improved ejection fraction compared with…
This cohort study evaluates the efficacy of neoadjuvant programmed cell death 1 protein (PD-1) or programmed cell death 1 ligand 1 (PD-L1) blockade combined with…
This study compares individuals who have discrepant biological and clinical stages with those who have congruent stages in terms of copathologies, comorbidities, and demographics.
This cross-sectional study examines the relative association of US Inflation Reduction Act (IRA) provisions with out-of-pocket costs for specialty drugs for Medicare Part D beneficiaries.